Axsome Therapeutics, Inc.
AXSM
$118.51
$1.371.17%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -246.90M | -278.27M | -287.22M | -310.96M | -308.55M |
| Total Depreciation and Amortization | 8.51M | 8.26M | 7.96M | 7.63M | 7.31M |
| Total Amortization of Deferred Charges | 2.36M | 2.69M | 2.64M | 2.39M | 2.34M |
| Total Other Non-Cash Items | 122.05M | 118.45M | 114.31M | 143.85M | 120.88M |
| Change in Net Operating Assets | -6.65M | 30.56M | 33.90M | 24.53M | 10.54M |
| Cash from Operations | -120.63M | -118.32M | -128.41M | -132.57M | -167.49M |
| Capital Expenditure | -471.00K | -510.00K | -270.00K | -247.00K | -528.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -471.00K | -510.00K | -270.00K | -247.00K | -528.00K |
| Total Debt Issued | 190.00M | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -193.55M | -1.23M | -990.00K | -660.00K | -349.00K |
| Issuance of Common Stock | 131.94M | 105.65M | 71.46M | 55.04M | 59.72M |
| Repurchase of Common Stock | -6.23M | -6.67M | -3.95M | -3.70M | -3.58M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -13.70M | -9.45M | -8.68M | -7.09M | -9.23M |
| Cash from Financing | 108.46M | 88.30M | 57.84M | 43.59M | 46.56M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.64M | -30.53M | -70.84M | -89.22M | -121.46M |